Peptron said Friday the company will unveil its new diabetes treatment, which works continuously for a month, at the American Diabetes Association (ADA) conference...
(Reuters) - The U.S. Food and Drug Administration on Tuesday rejected Prevention Bio Inc.'s approval of the experimental diabetes drug teplizumab, citing insufficient data,...